RxDoctor Payments Data

Rogelio Fernandez, MD

Family Medicine · Parlier, CANPI 1407953300

Payments from drug & device makers

$702in general payments, 2019–2025

Across 36 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$142
  • Novo Nordisk$108
  • AstraZeneca$108
  • Pfizer$104
  • Dynavax Technologies Corporation$63
  • GSK$54
  • plus $123 from 5 others

What the payments were for

  • Food & beverage$702100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$702 in reported general payments places this provider in the 65th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$49,725
Medicare patients
100
Services billed
790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$40,170
JardianceEmpagliflozin12$20,339
EliquisApixaban15$14,023
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,194
Atorvastatin Calcium176$2,071
Albuterol Sulfate HfaAlbuterol Sulfate49$2,029
Esomeprazole Magnesium18$1,525
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,310
Metformin Hcl88$1,004
Pioglitazone Hcl48$820
Gabapentin53$781
Lisinopril90$773
Amlodipine Besylate104$718
Tamsulosin Hcl43$705
Losartan Potassium72$569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$108$40,17024 claims
Boehringer IngelheimJardiance$17$20,33912 claims
PfizerEliquis$104$14,02315 claims
GSKTrelegy Ellipta$54$8,19413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 10,533 family medicine providers in California.

Other family medicine in Parlier

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →